Skip to main content
Equibles

SUSQUEHANNA INTERNATIONAL GROUP, LLP

Position in XGN — Exagen Inc.

CIK 1446194 BALA CYNWYD, PA
Back to XGN Full portfolio

Position in XGN

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$76,428
-$1,767,715 QoQ
Shares Held
25,476
-91.6% QoQ
Ownership
0.105%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2022
7 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in XGN Over Time

Shares Held

Position Value (USD)

Derivatives in XGN

reported options exposure · as of Dec 31, 2022
CallValue
$170,400
CallShares
71,000
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Diagnostics & Research

Healthcare · as of Jun 30, 2026

SUSQUEHANNA INTERNATIONAL GROUP, LLP holds $350,142,810 across 32 Diagnostics & Research names.

# Ticker Company Shares Value (USD) Open
1 GH
Guardant Health, Inc.
 644,138 $96,640,024
2 DHR
Danaher Corp /De/
 225,380 $42,930,380
3 NTRA
Natera, Inc.
 133,758 $36,308,609
4 TMO
Thermo Fisher Scientific Inc.
 69,202 $34,695,114
5 IDXX
Idexx Laboratories Inc /De
 54,439 $28,658,866
6 IQV
Iqvia Holdings Inc.
 82,213 $15,885,195
7 ILMN
Illumina, Inc.
 67,131 $11,803,643
8 GRAL
GRAIL, Inc.
 155,295 $10,601,989

All Filings in XGN

Export CSV
8 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $76,428 25,476
2025-12-31 $1,844,143 303,313
2025-09-30 $2,221,628 202,150
2022-12-31 $170,400 71,000
2022-09-30 $222,220 82,000
2022-06-30 $97,086 16,914
2022-06-30 $771,456 134,400
2022-03-31 $974,039 121,300